Search

everythinglearnresearchcommunity

for

Search:↓

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Before treating hair loss, it's crucial to diagnose and treat any underlying medical conditions that may be causing it.

Ring Chromosome 11 may be linked to conditions like early puberty, excessive hair growth, hair loss, and type 2 diabetes.

Ethnicity affects how polycystic ovary syndrome shows up in women, with white women having higher metabolic risks but less diabetes, and South Asian women showing more androgenic symptoms and being younger at presentation.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Serenoa repens may cause early puberty and should be used cautiously in children.

The document suggests that male hormones likely affect hair growth and baldness, and future treatments might involve stem cells and androgen-independent cells.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.

Saw palmetto extract can block the enzyme that converts testosterone in pig prostate cells.

The commentary suggests that certain hair and skin care products may be linked to frontal fibrosing alopecia, but not sunscreens, and calls for more thorough research on the causes.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Canine hypothyroidism can be linked to diabetes, requiring thorough testing for proper diagnosis.

Polycystic ovaries are defined by having 12 or more small follicles in each ovary and are found in up to 33% of women, while Polycystic Ovary Syndrome (PCOS) is the most common hormone disorder in women of reproductive age, potentially increasing risk of obesity, diabetes, and heart diseases.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

High insulin levels are more common and a better predictor of carbohydrate issues in women with PCOS than glucose tolerance tests.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.